Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CanaQuest Medical Corp CANQF

Biotechnology
CanaQuest Medical Corp is a Canada-based clinical-stage, life sciences company. The Company is focused on the drug discovery and development of targeted therapeutics within the endocannabinoidome, including PPAR receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and post-traumatic stress disorder (PTSD). It has created a natural formulation derived from cannabidiol + proprietary API composition. The Company has a drug candidate, CQ-001, positioned for clinical trials targeting epilepsy. Its CQ-001 drug candidate combines cannabidiol (CBD) with essential fatty acids (Omega-3s). In addition, the Company is also focused on developing a nutraceutical version of the formulation, Mentanine, which is scheduled for clinical studies to investigate its potential applications across various indications, paving the way for future clinical trials.


OTCPK:CANQF - Post by User

CanaQuest Medical Corp
Bullboard Posts
User Avatar Image
(2)
•••
Post by basslifton Jan 09, 2018 3:25pm
81 Views
Post# 27316289

Who’s in?!

Who’s in?!...
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities